Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 976 | 91 | 0.6778 | 0.5614 | 0.0932 | 0.0959 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 2 | 1617 | 91 | 0.4402 | 0.4191 | 0.0563 | 0.0616 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 882 | 92 | 0.6051 | 0.5813 | 0.1043 | 0.1242 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 471 | 92 | 0.2903 | 0.2918 | 0.1953 | 0.1993 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 2276 | 92 | 0.1106 | 0.1200 | 0.0404 | 0.0313 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 1177 | 92 | 0.3539 | 0.5276 | 0.0782 | 0.0734 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3458 | 92 | 0.1704 | 0.1709 | 0.0266 | 0.0246 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 3852 | 93 | 0.2045 | 0.1991 | 0.0241 | 0.0233 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 4327 | 93 | 0.2216 | 0.2010 | 0.0215 | 0.0218 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 3 | 309 | 93 | 0.2121 | 0.3656 | 0.3010 | 0.2907 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1311 | 94 | 0.7498 | 0.6679 | 0.0717 | 0.0750 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1266 | 94 | 0.7221 | 0.6679 | 0.0742 | 0.0750 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 2285 | 94 | 0.6321 | 0.4655 | 0.0411 | 0.0405 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 2 | 1016 | 94 | 0.2660 | 0.2591 | 0.0925 | 0.0924 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 4429 | 94 | 0.2727 | 0.2659 | 0.0212 | 0.0217 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 652 | 95 | 0.1607 | 0.1873 | 0.1457 | 0.1549 |
A-375 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 3 | 6342 | 95 | 0.4770 | 0.4690 | 0.0150 | 0.0238 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 2405 | 95 | 0.7534 | 0.5199 | 0.0395 | 0.0507 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 345 | 95 | 0.1995 | 0.3311 | 0.2754 | 0.2885 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 1917 | 95 | 0.5943 | 0.7294 | 0.0496 | 0.0484 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1259 | 96 | 0.3793 | 0.4386 | 0.0763 | 0.0724 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 911 | 96 | 0.2351 | 0.3742 | 0.1054 | 0.0960 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 1598 | 96 | 0.4333 | 0.5367 | 0.0601 | 0.0669 |
MZ7-mel | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1331 | 96 | 0.2714 | 0.3676 | 0.0721 | 0.0695 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1837 | 96 | 0.3501 | 0.3242 | 0.0523 | 0.0687 |